Literature DB >> 27649690

Predictors of long-term compensatory response of pulmonary function following major lung resection for non-small cell lung cancer.

Yusuke Takahashi1, Noriyuki Matsutani1, Shigeki Morita2, Hitoshi Dejima1, Takashi Nakayama1, Hirofumi Uehara1, Masafumi Kawamura1.   

Abstract

BACKGROUND AND
OBJECTIVE: Long-term pulmonary function which might include compensatory response (CR) significantly influences quality of life of long-term survivor after major lung resection. We investigated long-term pulmonary function after major lung resection.
METHODS: A total of 137 patients who had undergone lobar resection for non-small cell lung cancer (NSCLC) from May 2013 to June 2014 had spirometry at 10-14 months after surgery. Actual post-operative forced expiratory volume in 1 s (FEV1 ) (FEV1apo )/predicted post-operative FEV1 (FEV1ppo ), actual post-operative forced vital capacity (FVC) (FVCapo )/predicted post-operative FVC (FVCppo ), its relationship with clinicopathological factors and immunohistochemistry for pro-surfactant protein C (pro-SPC), thyroid transcription factor-1 (TTF-1) and vascular endothelial growth factor receptor 2 (VEGFR2) were investigated.
RESULTS: FEV1apo /FEV1ppo showed strong correlation with FVCapo /FVCppo (r = 0.628; P < 0.001). We defined greater CR as both FEV1apo /FEV1ppo and FVCapo /FVCppo were >120%. Greater CR was significantly associated with decreased smoking index (P < 0.001) and greater resected subsegments (P = 0.037). The never-smoker group revealed significantly greater CR compared with the smoker group in both FEV1apo /FEV1ppo (119.9 ± 12.5% vs 107.5 ± 14.2%; P = 0.030) and FVCapo /FVCppo (117.9 ± 9.98% vs 107.2 ± 13.1%; P = 0.046) in case-matched comparison. The expression of pro-SPC, TTF-1 and VEGFR2 in the normal lung parenchyma of greater CR group was significantly higher than those of lesser CR group (P < 0.001 for each). In addition, pro-SPC, TTF-1 and VEGFR2 expressions showed a significant correlation to the degree of CR especially in the smoker group (r = 0.631, 0.705 and 0.732, respectively; P < 0.001 for each).
CONCLUSION: Our data suggest that smokers may develop lesser long-term CR after major lung resection. Decreased expression of pro-SPC, TTF-1 and VEGFR2 may indicate decreased capacity of CR, especially in patients who smoke.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  airway epithelium; lung cancer; respiratory function tests; thoracic surgery

Mesh:

Substances:

Year:  2016        PMID: 27649690     DOI: 10.1111/resp.12904

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Factors associated with compensatory lung growth after pulmonary lobectomy for lung malignancy: an analysis of lung weight and lung volume changes based on computed tomography findings.

Authors:  Ikuma Wakamatsu; Haruhisa Matsuguma; Rie Nakahara; Masayuki Chida
Journal:  Surg Today       Date:  2019-08-22       Impact factor: 2.549

2.  Is skeletal muscle mass an optimal marker for postoperative outcomes in lung cancer patients?

Authors:  Yusuke Takahashi; Takeo Nakada; Noriaki Sakakura; Hiroaki Kuroda
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

3.  Mediastinal pulmonary artery is associated with greater artery diameter and lingular division volume.

Authors:  Hitoshi Dejima; Yusuke Takahashi; Tai Hato; Katsutoshi Seto; Tetsuya Mizuno; Hiroaki Kuroda; Noriaki Sakakura; Masafumi Kawamura; Yukinori Sakao
Journal:  Sci Rep       Date:  2017-04-28       Impact factor: 4.379

4.  A preliminary study identifies early postoperative lung volume changes in patients with non-small cell lung cancer following video-assisted thoracic surgery using CT volumetry.

Authors:  Xiaojun Du; Haojun Li; Langbo Liu; Min Zhang; Zhongben Tang; Jian Zhang; Peng Lin; Hong Xie; Cheng Chen
Journal:  Mol Clin Oncol       Date:  2021-04-22

5.  Nuclear factor-kappa B influences early phase of compensatory lung growth after pneumonectomy in mice.

Authors:  Yusuke Takahashi; Noriyuki Matsutani; Hitoshi Dejima; Takashi Nakayama; Hirofumi Uehara; Masafumi Kawamura
Journal:  J Biomed Sci       Date:  2017-07-05       Impact factor: 8.410

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.